Evidence map›Paper›PMID 30978539›Full record

ArticleRedox biology2019

TLR4 participates in sympathetic hyperactivity Post-MI in the PVN by regulating NF-κB pathway and ROS production.

Yu Wang, Hesheng Hu, Jie Yin, Yugen Shi, Jiayu Tan, Lu Zheng, Cailing Wang, Xiaolu Li, Mei Xue, Ju Liu and 6 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Yu WangDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Hesheng HuDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Jie YinDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Yugen ShiDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Jiayu TanDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Lu ZhengDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Cailing WangDepartment of Endocrinology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Xiaolu LiDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Mei XueDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Ju LiuMedical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Ye WangDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Yan LiMedical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Xinran LiDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Fuhong LiuMedical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Qiang LiuMedical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Suhua YanDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China. Electronic address: yansuhua296@163.com.
Shandong University · CNShandong Provincial QianFoShan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sympathetic nerve hyperactivity is a primary reason for fatal ventricular arrhythmias (VAs) following myocardial infarction (MI). Pro-inflammatory cytokines produced in the paraventricular nucleus (PVN) post-MI are associated with sympathetic overexcitation; however, the precise mechanism needs further investigation. Our aim was to explore the mechanism of toll-like receptor 4 (TLR4) and its downstream molecular pathway in mediating sympathetic activity post-MI within the PVN. A rat MI model was developed via left anterior descending coronary artery ligation. TLR4 was primarily localized in microglia and increased markedly within the PVN at 3 days in MI rats. Sympathoexcitation also increased, as indicated by high levels of renal sympathetic nerve activity (RSNA) and norepinephrine (NE) concentration. TLR4 knockdown via shRNA microinjection to the PVN resulted in decreased activation of Fos protein (+) neurons in the PVN and peripheral sympathetic nerve activity. TLR4 knockdown also exhibited a lower arrhythmia score following programmed electrical stimulation than those treated with MI surgery only, indicating that the knockdown of TLR4 decreased the incidence of malignant ventricular arrhythmias following MI. LPS-induced inflammatory response was analyzed to explore the underlying mechanism of TLR4 in sympathetic hyperactivity. High levels of NF-κB protein, the pro-inflammatory cytokines IL-1β and TNF-α, and ROS production were observed in the LPS group. PVN-targeted injection of the NF-κB inhibitor PDTC attenuated NF-κB expression and sympathetic activity. Taken together, the results suggested that knockdown of microglial TLR4 within the PVN decreased sympathetic hyperactivity and subsequent VAs post-MI. The downstream NF-κB pathway and ROS production participated in the process. Interventions targeting TLR4 signaling in the PVN may be a novel approach to ameliorate the incidence of VAs post-MI.

Indexed as

Signal TransductionAnimalsBiomarkersElectrocardiographyFluorescent Antibody TechniqueImmunohistochemistryMaleMyocardial InfarctionNF-kappa BParaventricular Hypothalamic NucleusRatsReactive Oxygen SpeciesSympathetic Nervous SystemToll-Like Receptor 4BiomarkersNF-kappa BReactive Oxygen SpeciesToll-Like Receptor 4Myocardial infarctionNF-κBPVNROSSympathetic hyperactivityTLR4

Identifiers

PMID30978539
PMCPMC6460304
OpenAlexW2933612009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.